Digital Vaccine Market Size, Share & Trends Analysis Report By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others), By Region, And Segment Forecasts, 2024-2031

The Global Digital Vaccine Market Size is valued at 1.61 billion in 2023 and is predicted to reach 3.73 billion by the year 2031 at a 11.25% CAGR during the forecast period for 2024-2031.

Digital Vaccines are a subset of digital therapeutics. Digital vaccines deploy applications on smartphones, tablets, and other similar devices for neurocognitive training to promote positive human behavior. The breakthrough in vaccine creation resulted recently with digital vaccines, which allowed for the developing antigens to utilize their molecular structure, commonly in conjunction with antibodies and made it feasible to create synthetic genes and deliver them as mRNAs. 

Digital therapeutics rapid technological development is accelerating the digital vaccine market expansion. The industry is further escalating due to advancements in digital vaccines like the Internet of Things (IoT), wearable technology, metaverse platforms, and Augmented Reality (AR/VR).

Digital vaccine Market demand is anticipated to be impacted by factors such as the growing population, increased research and developments activities, rise in the number of individuals suffering from different diseases, improved collaboration with progressive governments, and acceptable funders and investors.

Several other vital global factors impacting the growth of the digital vaccine market are data privacy laws and the growing use of digital vaccinations in the healthcare industry. Another significant factor affecting the digital vaccine market growth rate is the rising healthcare expense, which helps build its infrastructure. 

Recent Developments:

• In Jun 2022, The US Patent and Trademark Office awarded FriendsLearn a patent for their systems and methods for the digital vaccine. FriendsLearn is the official research partner of the 'digital vaccine initiative' at Carnegie Mellon University in Pittsburgh, United State.FriendsLearn has begun planning for randomised controlled clinical trials (RCT) with the objective of measuring the effects of Digital vaccines combined with Artificial Intelligence on cholesterol, blood glucose, ketones, glycoprotein acetyls, amino acids, and body mass index. 

Competitive Landscape:

Some of the Digital Vaccine market players are:

• FriendsLearn Inc.,
• Klein Buendel Inc.
• Sanofi S.A
• Evidation Health
• Atos SE
• oVRcome 

Market Segmentation:

The digital vaccine market is segmented on the device used and applications. Based on the device used, the market is segmented into smartphones, tablets and others. Based on applications, the digital vaccine market is segmented into covid-19, influenza, diabetes, cardiovascular diseases, hypertension and Others.

Based On device, Smartphone Segment Is A Major Contributor To The Digital Vaccine Market

The market's leading segment is smartphone. Increased adoption of premium smartphone designs, high disposable income, strong internet connectivity use of mobile internet, and an increase in population technological approach are the key drivers of smartphone use. Through ongoing behavioral interventions, smartphone developments in digital vaccinations help deliver many medical diseases at a much-reduced rate.

The Infectious Diseases Segment Witnessed Growth At A Rapid Rate

Infectious Diseases grabbed the highest revenue share and anticipated to continue to hold that position during the forecast time. Increased incidence of infectious diseases, such as hepatitis, influenza, COVID-19, and human immunodeficiency virus, is the primary factor driving the global market expansion. According to mortality surveillance statistics from the National Center for Health Statistics (NCHS) that were available on April 6, 2023, pneumonia, influenza, and/or COVID-19 were responsible for 7.9% of fatalities that occurred during the week ending April 1, 2023 (PIC).

The prevalence of infectious diseases in both developed and developing regions will positively affect market growth. The occurrence of Covid-19 pandemic emerged as a significant market growth factor.

Although typically, vaccine research takes years to complete the necessary testing, governments and medical agencies hastened vaccine development in response to the outbreak's severity. The World Health Organization (WHO) and various government regulatory agencies have launched several initiatives due to the quick advancement of vaccine research.

The North American Digital Vaccine Market Holds A Significant Regional Revenue Share

The North American digital vaccine market is anticipated to register the highest market share, and this is because the region has essential key players and developed healthcare infrastructure. Regional development is anticipated to be fueled by a rising patient base, increased healthcare investment, and government assistance. In addition, Asia Pacific is projected to grow rapidly in the global digital vaccine market because more infectious diseases are emerging, and governments are supporting immunization.

Digital Vaccine Market Report Scope:

Segmentation of Digital Vaccine Market-

Digital Vaccine Market By Device Used:

• Smartphones
• Tablets
• Others

Digital Vaccine Market By Application:

• Diabetes
• Infectious Diseases
• Cardiovascular Diseases
• Others

Digital Vaccine Market By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa